Epilepsy Alliance America is a proud member of the International Bureau for Epilepsy. In recognition of November as Epilepsy Awareness Month, the North America region of the International Bureau for […]

Read Full Post

Call to action: Are you a parent or caregiver of a child with epilepsy? Help researchers at Duke University understand how healthcare providers can best communicate information about Sudden Unexpected […]

Read Full Post

Epilepsy Alliance America is proud to be supporting Safe Step Act (HR 2163 / S464) This legislation would provide patients and providers with a clear and transparent appeals process when subject […]

Read Full Post

Fireside Chat about Epilepsy Alliance America Epilepsy Alliance America Board members, Jeff Sinsebox and Adeola Sonaike, sit down with Eysz founder, Rachel Kuperman, about their work with Epilepsy Alliance America.

Read Full Post

Thanks to the generosity of Dr. Lorna Myers who is donating the royalties of her book, PSYCHOGENIC NON-EPILEPTIC SEIZURES: A GUIDE, Epilepsy Alliance America has established a scholarship program for […]

Read Full Post

Epilepsy Alliance America is pleased to announce we have joined as a member of the Alliance for Comprehensive Testing (ACT), or ACT Against COVID. As a member of the alliance, we’re dedicated to educating the […]

Read Full Post

The safety and well-being of those in the epilepsy community who were impacted by the widespread devastation caused by Hurricane Ida in both the Gulf region and in the Northeast […]

Read Full Post

Epilepsy Alliance America is proud to have joined the International Bureau for Epilepsy (IBE) as an Associate Chapter member.  EAA’s participation was ratified at the IBE’s General Assembly meeting on […]

Read Full Post

A special promo offer is now available for the EAA Network — a 30% discount off of regular priced Student/Family Caregiver tickets. The discount is available only through this special link. […]

Read Full Post

Epidiolex®, a cannabidiol (CBD) oral solution by Greenwich Biosciences, is now indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) or Tuberous Sclerosis Complex in […]

Read Full Post